ATG-001

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameATG-001
Drug Alias Namenicotinic acetylcholine receptor inhibitor (CoMentis)nicotinic acetylcholine receptor inhibitor (Athenagen)ATG-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinic receptors antagonists
TargetsNicotinic receptors
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesComentis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesComentis Inc
Active IndicationsN/A
Inactive IndicationsMacular Degeneration

Other Information

ATC CodeN/A
Related LinksN/A